List view / Grid view

Professor Sir Mark Pepys FRS FMedSci (University College London)

 

article

Academia Big Pharma collaboration in drug development

5 May 2014 | By

Clearly what is needed is a synergistic collaboration bringing together the respective competence and expertise of academia and industry. All the major pharmaceutical companies have recognised this need and have introduced a range of different models for association with academia and small biotech or biopharma companies. Attempted solutions range from…